Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Hepatitis, Autoimmune

1-anilino-8-naphthalenesulfonate has been researched along with Hepatitis, Autoimmune in 3 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Hepatitis, Autoimmune: A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.

Research Excerpts

ExcerptRelevanceReference
"Fibrosis progression in autoimmune hepatitis can be attenuated by immunosuppressive treatment; however, some patients progress despite therapy."1.56The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. ( Großhennig, A; Kirstein, MM; Manns, MP; Marhenke, S; Mederacke, I; Mederacke, YS; Metzler, F; Vogel, A, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Mederacke, YS2
Kirstein, MM1
Großhennig, A1
Marhenke, S1
Metzler, F1
Manns, MP1
Vogel, A1
Mederacke, I2
Huang, JF1
Chuang, WL1

Other Studies

3 other studies available for 1-anilino-8-naphthalenesulfonate and Hepatitis, Autoimmune

ArticleYear
The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
    Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; Ge

2020
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease. Authors' reply.
    Alimentary pharmacology & therapeutics, 2020, Volume: 52, Issue:2

    Topics: Genotype; Hepatitis, Autoimmune; Humans; Lipase; Non-alcoholic Fatty Liver Disease; Prognosis

2020
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease.
    Alimentary pharmacology & therapeutics, 2020, Volume: 52, Issue:2

    Topics: Genotype; Hepatitis, Autoimmune; Humans; Lipase; Non-alcoholic Fatty Liver Disease; Prognosis

2020